Andrew A de Oliveira (Andrew A Oliveira)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Plasmodium Falciparum

Genetic Diversity

Top Venues

ACS bio & med chem Au

Drug development research

Molecules (Basel, Switzerland)

Universidade de São Paulo Câmpus de São Carlos

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de São Paulo Câmpus de São Carlos Jul 27 2013 - Sep 06 2019

Brazil

Ph.D Student :: Instituto de Física de São Carlos

Publications

Larissa G Maciel, Matheus Vitor Ferreira Ferraz, Andrew A de Oliveira, Roberto Dias Lins Neto, Janaína V Dos Anjos, Rafael Victorio Carvalho Guido, Thereza A Soares
Inhibition of 3-Hydroxykynurenine Transaminase from Aedes aegypti and Anopheles gambiae : A Mosquito-Specific Target to Combat the Transmission of Arboviruses. ACS bio & med chem Au 3 (2) (2023)
Larissa G Maciel, Matheus Vitor Ferreira Ferraz, Andrew A de Oliveira, Roberto Dias Lins Neto, Janaína V Dos Anjos, Rafael Victorio Carvalho Guido, Thereza A Soares
Inhibition of 3-Hydroxykynurenine Transaminase from Aedes aegypti and Anopheles gambiae : A Mosquito-Specific Target to Combat the Transmission of Arboviruses. ACS bio & med chem Au 3 (2) (2023)
Bruna F Mazzeu, Tatiana M Souza-Moreira, Andrew A de Oliveira, Melissa Remlinger, Lidiane G Felippe, Sandro R Valentini, Rafael Victorio Carvalho Guido, Cleslei F Zanelli, Maysa Furlan
The Methionine 549 and Leucine 552 Residues of Friedelin Synthase from Maytenus ilicifolia Are Important for Substrate Binding Specificity. Molecules (Basel, Switzerland) 26 (22) (2021)
Mariana L Garcia, Andrew A de Oliveira, Renata Vieira Bueno, Victor H R Nogueira, Guilherme Eduardo de Souza, Rafael Victorio Carvalho Guido
QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity. Drug development research (2020)